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Abstract
 
We have previously hypothesized that maintaining a balanced peripheral immune system may
not be the sole responsibility of a specialized subset of T cells dedicated to immune regulation,
but also a side effect of normal competition for shared resources within an intact immune sys-
tem. Here we show that regulatory activity is correlated with high homeostatic expansion po-
tential, reflecting the avidity for self-peptide:MHC complexes. Monoclonal transgenic T cells
with high homeostatic expansion potential and lacking characteristics previously associated
with regulatory function were able to regulate wasting disease induced by transfer of a small
number of naive CD45RB
 
hi
 
 CD4 T cells into lymphopenic hosts. Self-regulatory function is
also found in the naive polyclonal T cell repertoire depleted of CD25
 
 
 
 T cells. T cells capable
of preventing immune pathology, like the transgenic T cells, express higher than average levels
of CD5, an indicator of avidity for self:MHC peptide complexes. We therefore propose that
dysregulated expansion of potentially pathogenic T cells in a lymphopenic environment can be
prevented by members of the naive T cell repertoire, irrespective of their specificity, as a side
effect of their response to homeostatic and antigenic stimulation.
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Introduction
 
Regulation or control of responsiveness is an intrinsic
property of the immune system. Excessive T cell responses
to self-antigens (autoimmune disease) or innocuous envi-
ronmental antigens (allergy) are usually prevented in the
vast majority of individuals. Furthermore, maximal re-
sponses to foreign antigens are also normally controlled by
a number of mechanisms, including competition between
responding T cells. This phenomenon is thought to be re-
sponsible for affinity maturation of the T cell response (1)
and helps prevent disproportionate damage to self (immu-
nopathology). The control mechanisms that maintain a sta-
ble and diverse repertoire of naive and memory T cells in a
healthy functional immune system (2, 3) are severely com-
promised in lymphopenic mice. For instance, thymectomy
shortly after birth or transfer of small numbers of T cells
into T cell–deficient hosts are consistently associated with
immunopathology and an array of autoimmune diseases (4–
8). Furthermore, responses to cognate antigens are also ex-
aggerated in lymphopenic hosts (9). Thus, lymphopenia is
invariably associated not only with homeostatic expansion
of the remaining T cells in response to endogenous MHC
ligands and IL-7, but also with immune reactivity both to
self- and foreign antigens that would not normally be appar-
ent in T cell–replete hosts.
Suppression of immune reactivity is currently attributed
to a population of regulatory T cells dedicated to maintain-
ing peripheral tolerance to self-antigens or preventing
harmful immunopathological responses (for a review, see
reference 10). Regulatory T cells, obtained from unmanip-
ulated hosts, are defined by markers such as CD25 (11) and
CTLA-4 (12, 13) and more recently expression of the glu-
cocorticoid-induced tumor necrosis factor receptor family
related gene (GITR; references 14 and 15) and may medi-
ate their function via release of inhibitory cytokines such as
TGF-
 
 
 
 and IL-10 (16–19) and/or cell contact dependent
mechanisms (14, 20). Although T cell–mediated regulation
of immune pathology is amply documented, it is not well
understood how many different types of regulatory T cells
there might be, how they are related and how they function.
We have previously suggested that maintaining a bal-
anced peripheral immune system may not be the sole re-
sponsibility of a specialized subset of T cells dedicated to
immune regulation, but rather a side effect of normal com-
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petition for shared resources within an intact immune sys-
tem (21). To demonstrate that T cell competition for
shared resources, independent of specificity, or effector
function can achieve T cell regulation, we employed one
of the most widely used animal models for studies of regu-
latory T cells. In this model severe gut pathology and wast-
ing disease are induced by transfer of a small number of na-
ive CD45RB
 
hi
 
 CD4 T cells into lymphopenic hosts and
pathology is prevented by cotransfer of cells from the recip-
rocal CD45RB
 
lo
 
 subset, especially those that also express
CD25. To demonstrate that competition for space by T
cells that do not have any of the characteristics associated
with regulatory T cells, can underlie regulatory activity we
employed monoclonal TCR transgenic T cells. We show
here that cotransfer of AND T cells with a defined anti-
genic specificity unrelated to that of the pathological
response can protect mice from pathology as well as
CD25
 
 
 
CD45RB
 
lo
 
 T cells. Regulatory function of AND T
cells did not require acquisition of markers previously asso-
ciated with regulatory function, but was correlated with
exceptionally high homeostatic expansion potential. Fur-
thermore, even monoclonal CD8 T cells from the OT-I
strain which expand considerably, if less than AND T cells,
in lymphopenic hosts afforded at least partial protection.
In addition, we demonstrate here that T cells with prop-
erties similar to AND T cells can also be found in the poly-
clonal naive CD4 T cell repertoire depleted of CD25
 
 
 
 T
cells. Such T cells, like AND T cells show increased ho-
meostatic expansion and express high levels of CD5, re-
flecting their avidity for self-peptide:MHC complexes (22,
23). CD5, a negative regulator of TCR signaling (24), is
up-regulated during thymic differentiation and ensures that
thymocytes with high avidity for self peptide:MHC com-
plexes are not overtly self-reactive in the periphery because
they display lower responsiveness to self-antigen (25). On
the other hand, CD5
 
hi
 
 T cells possess higher homeostatic
expansion potential to self peptide:MHC signals than their
CD5
 
lo
 
 counterparts (26). Cells that are involved in negative
regulation may therefore be members of the naive T cell
repertoire that fulfill this function not as their sole purpose,
but rather as a side effect of their response to homeostatic
and antigenic stimulation.
 
Materials and Methods
 
Mice.
 
Mice of strain A (H-2
 
a
 
) and C57BL/10 (H-2
 
b
 
), wild-
type and backcrossed onto a Rag-1
 
 
 
/
 
 
 
 background, and TCR
transgenic AND mice, on a Rag-1
 
 
 
/
 
 
 
 H-2
 
a
 
 MHC and Rag-1
 
 
 
/
 
 
 
H-2
 
b
 
 background, as well as OT-I Rag1
 
 
 
/
 
 
 
 mice were bred and
maintained in the animal facilities of the National Institute for
Medical Research in accordance with established guidelines.
 
Flow Cytometry.
 
Conjugated mAb were purchased from BD
Biosciences and flow cytometric analyses were performed using
standard staining procedures on FACScan™ and FACSCalibur™
cytometers with CELLQuest™ software. For intracellular cyto-
kine stainings mesenteric lymph node cell suspensions were stim-
ulated for 4 h with PdBU and ionomycin (both at 50 ng/ml). For
the last 2 h Brefeldin A (10 
 
 
 
g/ml) was added to the cultures.
Cells were washed and stained for CD4 and V
 
 
 
11, fixed in 1%
PFA, and permeabilized in 0.1% NP-40. After washing, unspe-
cific staining was blocked with anti-FcR (2.4G2) and cells were
stained with anti–IL-10 APC in conjunction with anti–IFN-
 
 
 
 PE
or anti–IL-2 PE. Intracellular CTLA-4 staining was performed
without the PdBU/ionomycin stimulation step.
 
Cell Sorting and Adoptive Transfer Experiments.
 
Single cell sus-
pensions of spleen and lymph nodes from 6- to 10-wk-old donor
mice were enriched for CD4 T cells using magnetic beads conju-
gated with CD4 beads (Miltenyi Biotech) on an AutoMACS.
Thereafter CD4 cells were sorted on a MoFlo cytometer accord-
ing to CD45RB, CD25, and CD5 expression as stated in the re-
spective experiments. Between 2 and 4 
 
 
 
 10
 
5
 
 (unless otherwise
stated) CD4 T cells were injected intravenously. In cotransfer ex-
periments equal numbers of each T cell population were in-
jected
 
.
 
 Recipient mice were weighed weekly and the weight on
the day of injection was set as 100%. Mice were culled when 20%
weight loss occurred and/or excessive diarrhea developed. The
assessment of mean survival time therefore corresponds with the
time point of 20% weight loss.
 
In Vitro Experiments.
 
In vitro suppression experiments were
done as described previously (27). Briefly, 5 
 
 
 
 10
 
4
 
 sorted
CD45RB
 
hi
 
 CD4 T cells were cultured in 96-well flat bottom
plates with 5 
 
 
 
 10
 
4
 
 irradiated (3,000 Rad) Rag
 
 
 
/
 
 
 
 spleen cells in
the presence of 0.5 
 
 
 
g/ml anti CD3 (2C11) mAb. Increasing
numbers of sorted ex vivo AND H-2
 
a
 
 Rag
 
 
 
/
 
 
 
 CD4 T cells, or
AND H-2
 
a
 
 Rag
 
 
 
/
 
 
 
 CD4 T cells resorted after transfer (4 
 
 
 
 10
 
5
 
AND T cells transferred into Rag
 
 
 
/
 
 
 
 H-2
 
a
 
 hosts 8 wk before the
experiment) or sorted CD25
 
 
 
CD45RB
 
lo
 
 CD4 T cells were
added to the cultures. After 48 h, supernatants were taken and
analyzed for IL-2 content in standard CTLL assay.
 
Results
 
Co-transfer of CD4 T Cells from AND Rag
 
 
 
/
 
 
 
 Mice Pre-
vents Immune Pathology in H-2
 
a
 
, but Not H-2
 
b
 
 Recipients of
CD45RB
 
hi
 
 CD4 T Cells.
 
Transfer of low numbers of
CD4 T cells expressing CD45RB at high levels into lym-
phopenic recipients results in immune pathology character-
ized by a wasting disease with severe weight loss, diarrhea,
and development of inflammatory bowel disease (IBD; ref-
erence 5). This can be prevented by cotransfer of
CD45RB
 
lo
 
 CD4 T cells and specifically those that also ex-
press CD25 (11). To test our hypothesis that competition
for space between T cell populations might underlie the
protective effect we chose as ‘regulatory’ population a
monoclonal transgenic T cell population with known anti-
genic specificity unrelated to that involved in development
of gut pathology in this system. Lymphopenic Rag
 
 
 
/
 
 
 
mice on an H-2
 
a
 
 MHC background (i.e., expressing class II
A
 
k
 
 and E
 
k
 
 molecules) were injected either with 2 
 
 
 
 10
 
5
 
sorted CD45RB
 
hi
 
 CD4 T cells from H-2
 
a
 
 mice only or
with a mixture of CD45RB
 
hi
 
 CD4 T cells (2 
 
 
 
 10
 
5
 
 of
each) and CD4 T cells from the AND Rag
 
 
 
/
 
 
 
 strain ex-
pressing H-2E
 
k
 
 or CD45RB
 
lo
 
 CD4 T cells which contain
regulatory T cells. AND T cells are known to rapidly di-
vide upon transfer into H-2E
 
k
 
 containing hosts (28, 29).
From 
 
 
 
4 wk after transfer all recipients of CD45RB
 
hi
 
 CD4
T cells alone lost weight and eventually developed severe
diarrhea so that they had to be culled around 6–7 wk after
transfer (Fig. 1 a, top row left). None of the animals thatT
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received AND Rag
 
 
 
/
 
 
 
 T cells together with CD45RB
 
hi
 
 T
cells developed such symptoms (Fig. 1 a, top row right) and
at termination of the experiment these mice were as
healthy as mice that had received cotransfer of CD45RB
 
lo
 
T cells (Fig. 1 a, top row middle).
Monitoring of CD4 T cell expansion in blood (Fig. 1 a,
middle row) over 50 d and in lymphoid organs upon ter-
mination of the experiment (Fig. 1 a, bottom row) showed
dramatic expansion of CD4 T cells in recipients of
CD45RB
 
hi
 
 CD4 T cells, whereas there was no equivalent
expansion over time in recipients cotransferred with AND
Rag
 
 
 
/
 
 
 
 T cells or CD45RB
 
lo
 
. On the other hand AND T
cells expanded enormously for the first 7 d after transfer as
evident from the proportion of AND T cells present in
blood on day 7. Although the number of AND T cells in
blood decreased from day 7 after transfer, they still com-
prised 35% of the cells in mesenteric lymph nodes and
more than 10% in spleen 50 d later (Fig. 1 a, bottom row).
Expansion of polyclonal CD4 T cells was most prominent
in the mesenteric lymph nodes draining the gut, but was
strongly reduced in mice that had been cotransferred with
AND T cells.
While AND T cells are known to have exceptionally
high expansion potential in H-2E
 
k
 
 expressing hosts, AND
T cells on an H-2
 
b
 
 background that also selects this T cell
receptor undergo more limited expansion in lymphopenic
hosts (28). We therefore performed a similar experiment
transferring CD45RB
 
hi
 
 CD4 T cells from H-2
 
b
 
 hosts with
AND T cells or CD45RB
 
lo
 
 cells from H-2
 
b
 
 donors into
Rag
 
 
 
/
 
 
 
 H-2
 
b
 
 mice. In this case cotransfer of AND T cells
did not protect the recipients from weight loss and devel-
opment of diarrhea, whereas CD45RB
 
lo
 
 cells prevented all
symptoms of gut pathology (Fig. 1 b, top panel). Analysis
of the CD4 T cell numbers revealed that AND T cells
from H-2
 
b
 
 mice did not expand extensively and also did
not prevent the expansion of the injected CD45RB
 
hi
 
 pop-
ulation (Fig. 1 b, bottom panel).
AND T cells did not express markers typically associated
with regulatory T cells, such as CD25 or CTLA-4 at the
time of transfer (Fig. 2 a), nor did they acquire a ‘classical’
regulatory phenotype during their expansion in vivo (Fig. 2
b). All AND T cells harvested from protected mice 8 wk
after transfer have an activated phenotype judged by high
levels of CD44 expression, but did not express CD25.
Their cytokine potential as revealed after restimulation in
vitro revealed IL-2 and 
 
 
 
-interferon activity, but no IL-10
production (Fig. 2 c).
A summary of experiments (endpoints 8–15 wk after
transfer) shown in Table I demonstrates that 75% of mice
which had received cotransfer of AND H-2
 
a
 
 T cells were
protected from disease similar to mice that had received
cotransfer of CD45RB
 
lo
 
 T cells (85% protected), whereas
Figure 1. TCR transgenic AND Rag /  CD4 T cells from H-2Ek , but not H-2Ab  mice can regulate CD45RBhi T cells in lymphopenic hosts. (A)
Equal numbers (2   105) of CD45RBhi and CD45RBlo or AND Rag /  T cells (all H-2a) were adoptively transferred into Rag /  H-2a hosts. Body
weight and percentage of T cells in the blood were monitored weekly and peripheral lymphoid organs were assessed for CD4 T cells as a proportion of
total live cells at the endpoint of the experiment. AND T cells were identified based on expression of V 11. (B) Equal numbers (2   105) of CD45RBhi
and CD45RBlo or AND Rag /  CD4 T cells (all H-2b) were adoptively transferred into Rag /  H-2b hosts. Body weight and percentage of T cells in
blood and lymphoid organs were monitored as in A.T
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454 T Cell Regulation by Competition
only 10% of mice injected with CD45RBhi T cells alone
did not develop pathology. On an H-2b background AND
T cells were unable to protect recipients against coli-
tis,  whereas 100% of mice that received cotransfer of
CD45RBlo T cells remained healthy. Thus, these experi-
ments show an intriguing correlation between regulatory
activity and the capacity for expansion in a lymphopenic
environment.
AND T Cells Are Not Suppressive In Vitro. Numerous
reports have shown in vitro suppressive activity of the
CD25  T cell population (for a review, see reference 30).
To assess whether the regulatory function of AND T cells
would be detectable in vitro, we set up standard mixtures
of T cells with irradiated spleen cells and anti-CD3 stimula-
tion. Coculture of fresh CD25  T cells suppressed IL-2
production and proliferation of CD45RBhi T cells as previ-
ously reported. However, AND T cells, taken either ex
vivo as naive T cells or after expansion in a lymphopenic
host, did not show any suppressive effect in vitro (Fig. 3,
left panel). On their own, CD3 stimulated AND T cells
produced IL-2, but much lower amounts than the poly-
clonal CD45RBhi population (Fig. 3, right panel) whereas
CD25  CD4 T cells did not make IL-2 at all. This indi-
cates that AND T cells do not share the ability for in vitro
suppression. On the other hand, in vivo suppression by
both CD25  CD4 T cells and AND T cells led to indistin-
guishable outcomes. Thus, in vitro suppression is not a pre-
requisite and might be of limited predictive value for in
vivo regulation.
Homeostatically Expanding CD8 T Cells Offer Partial Pro-
tection. While the AND TCR transgenic strain served as
an example of a monoclonal T cell population that was able
to regulate immune pathology irrespective of its unrelated
antigenic specificity and phenotype, the expansion capacity
of AND T cells in lymphopenic hosts is exceptional and
does not resemble that of any other TCR transgenic strain.
One might therefore be concerned to link protective func-
tion to homeostatic expansion potential based on this strain
alone. To further substantiate our claim that homeostatic
expansion of transgenic T cells in a lymphopenic host can
interfere with the induction of immune pathology by
CD45RBhi polyclonal T cells, we used another TCR
transgenic strain on a Rag /  background, OT-I. CD8 T
Figure 2. Activation markers
and cytokine expression. (A)
Polyclonal and AND Rag / 
CD4 T cells (all H-2a) were
stained for CD25 and intracellu-
lar CTLA-4 (shaded histograms  
isotype control). (B) CD25 and
CD44 expression on polyclonal
and AND Rag /  CD4 T cells
(mesenteric lymph nodes) after
adoptive transfer into Rag / 
H-2a hosts (experiment from
Fig. 1 A). (C) IFN- , IL-2,
and IL-10 expression on AND
Rag /  CD4 T cells ex vivo and
after adoptive transfer with
CD45RBhi CD4 T cells into
Rag /  hosts (all H-2a). Percent-
ages are indicated in the histo-
grams and dot plots.
Table I. Summary of Adoptive Transfer Experiments with AND 
TCRtg CD4 T Cells
Percentage of protected mice (total mice)
CD45RBhi CD45RBhi   RBlo CD45RBh i  AND
H-2a 10 (10) 85 (7) 75 (12)
H-2b 8 (12) 100 (8) 8 (12)T
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cells from the OT-I strain have been shown to undergo
substantial expansion and phenotypic conversion upon
transfer into lymphopenic hosts (31). As CD4 and CD8 T
cells to some extent share a peripheral niche (3), homeo-
static expansion of one population would be expected to
affect the other. Although OT-I T cells divide extensively,
their proliferation is much less pronounced than that of
AND T cells, illustrated by the CFSE profile shown in Fig.
4 a. Nevertheless, cotransfer of OT-I T cells had a strong
effect on immune pathology caused by CD4 CD45RBhi T
cells, delaying the onset of disease and protecting 50% of
the mice completely.
Self-regulation by High Numbers of CD45RBhi CD4 T
Cells. Excessive expansion may be more pronounced
with a small inoculum of T cells that encounters unlimited
resources than with larger numbers of T cells that would
compete amongst each other for factors controlling their
expansion. To test this assumption, we compared groups of
mice that received either 4   105, 6   106, or 12   106
sorted CD45RBhiCD25  CD4 T cells (Fig. 5 a). While the
recipients of the smallest cell dose had all developed symp-
toms of colitis by 3–4 wk (Fig. 5 b), transfer of higher
numbers of T cells showed either partial protection, pre-
venting disease in 3 out of 5 animals (Fig. 5 b, left) or in the
case of the highest dose complete protection (Fig. 5 b,
right). T cells in lymphoid organs from recipients of the
high dose of CD45RBhi cells were not all activated, as
shown by retention of the CD45RBhi marker in 26% of
the cells compared with 9% of the cells from recipients of
the low dose (Fig. 5 c, top panel). Furthermore, while 92%
of the transferred T cells found in recipients of small num-
bers of CD45RBhi cells expressed high levels of CD44 in-
dicating their activation, only 58% of the T cells in mice
that had received high doses of CD45RBhi cells showed an
activated phenotype (Fig. 5 c, bottom panel). This finding
is compatible with the hypothesis that competition with
neighboring T cells for limited resources may restrain ex-
cessive activation and outgrowth of transferred T cells.
Immune Regulation by CD5hiCD45RBhi Polyclonal T
Cells. Self-regulation after transfer of large numbers of
CD45RBhiCD25  T cells into lymphopenic hosts indi-
cated the existence of a subset of T cells within this popula-
tion which, similarly to AND T cells, could inhibit the de-
velopment of immune pathology. Although AND T cells
might represent an extreme example, we hypothesized that
T cells with similar properties that might make them ‘regu-
latory’ are also contained in the polyclonal repertoire. Ex-
trapolating from the behavior of AND T cells transferred
into H-2Ek  recipients, such cells would be expected to
have high avidity for self-peptide:MHC. One of the hall-
marks of avidity for self peptide:MHC is the level of ex-
pression of CD5, a negative regulator of TCR signaling. As
the strength of interaction with self-peptide: MHC is re-
flected in the levels of expression of CD5, we compared
CD5 expression on AND cells and polyclonal CD45RBhi
T cells. As shown in Fig. 6 a, CD5 expression on AND T
cells on an H-2Ek  background falls within the high range
of expression levels on polyclonal T cells, correlating well
with their reported high avidity for self peptide:MHC.
CD5 expression of AND T cells on an H-2b background,
on the other hand, falls within the lower expression levels
of polyclonal T cells in agreement with their reported
lower avidity (32). When analyzing T cells in adoptive
hosts of CD45RBhi T cells that succumbed to disease
(transfer of low T cell numbers middle panel) with those
that remained healthy (transfer of high T cell numbers top
panel), it was clear that healthy mice contained a larger
proportion of CD5hi T cells, whereas in sick animals CD5lo
T cells predominated (Fig. 6 b). We therefore hypothesized
that CD5lo T cells may be enriched in potentially patho-
genic T cells. These may normally be kept in check by
CD5hi T cells in the repertoire that out compete them due
to their higher avidity for self peptide:MHC complexes on
APCs; their decreased responsiveness to cognate antigens,
on the other hand, would make CD5hi T cells less likely to
cause immune pathology themselves.
Figure 3. AND T cells do not suppress in vitro Sorted naive ex vivo
AND T cells ( ,  ), sorted AND T cells after homeostatic expansion in
a lymphopenic host ( ,  ), or sorted ex vivo CD25  T cells ( ,  )
were cultured in the presence of anti-CD3 with irradiated Rag /  spleen
cells and with (open symbols) or without (filled symbols) sorted syngeneic
CD45RBhi CD4 T cells. Supernatants were assessed for IL-2 content in a
standard CTLL assay.
Figure 4. CD8 T cells from OT-I show regulatory ac-
tivity. (A) OT-I H-2b and AND Rag /  H-2a T cells were
labeled with CFSE and transferred into corresponding syn-
geneic Rag /  hosts. The CFSE profiles were assessed 7 d
later. (B) 4   105 CD45RBhi CD4 T cells from H-2b B10
mice were adoptively transferred either alone (n   3,  )
or together with the same number of OT-I Rag /  T cells
(n   9,  ) into syngeneic Rag /  hosts and monitored
for body weight weekly. The figure shows cumulative
incidence of 20% weight loss at which time mice had to
be culled.T
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To test this hypothesis, CD45RBhiCD25  T cells were
sorted for low and high CD5 expression and 3   105
sorted CD5hi or CD5lo (see Fig. 6 c) were transferred
into lymphopenic hosts and compared with unseparated
CD45RBhiCD25  cells (Fig. 6 d). Mice that received
CD45RBhi CD25  T cells all developed disease with a
mean survival time of 44.3   11.9 d after injection. Mice
that received the sorted CD5lo population succumbed to
disease significantly earlier with a mean survival time of
30.1   6.5 d (P   0.005). In contrast, onset of disease in
recipients of the CD5hi subset was substantially delayed
(mean survival time 57.1   12.0 d, P   0.05) and 40% of
Figure 5. Transfer of high numbers of CD45RBhi CD4 T cells does not lead to
immune pathology. (A) Phenotype of sorted CD45RBhi CD25 negative and
CD45RBlo CD25 positive CD4 T cells. (B) 4   105 ( , n   5) and 6   106 ( , n  
5) or 4   105  , n   5) and 12   106 ( , n   4) CD45RBhi CD25 negative CD4 T
cells from H-2b B10 mice were adoptively transferred into syngeneic Rag /  hosts and
monitored for body weight weekly. The figure shows cumulative incidence of 20%
weight loss at which time mice had to be culled. (C) CD45RB expression (top panel)
and CD44 expression (bottom panel) on peripheral CD4 T cells from B10 control
mice as well as mice that received a high dose (12   106) of CD45RBhi CD4 T cells
(healthy and killed 80 d after transfer), or mice that received a low dose (4   105) of
CD45RBhi T cells (killed 35 d after transfer because of severe weight loss and diarrhea).
Percentages are indicated in the histograms.
Figure 6. CD45RBhi CD5hi
CD4 T cells act as regulatory T
cells. (A) CD5 expression on
AND CD4 T cells (shaded histo-
gram) and on polyclonal CD4 T
cells (open histogram) on differ-
ent MHC backgrounds. (B)
CD5 expression on peripheral
CD4 T cells from experiment
described in Fig. 3 B. B10 con-
trol, (black histogram), low dose
recipient (4   105 CD45RBhi,
gray histogram), and high dose
recipient (12   106 CD45RBhi,
open histogram). (C) CD5 phe-
notype of sorted CD45RBhi
CD25  CD4 T cells. (D) Cu-
mulative incidence of 20%
weight loss in groups of mice re-
ceiving 3–4   105 CD45RBhi
CD4 T cells which were either
unseparated ( , n   14) or sorted into CD5hi ( , n   12) and CD5lo ( , n   10). (E) Mean CD5 fluorescence on peripheral blood lymphocytes over
time in mice receiving sorted CD5lo (white bars, n   5) or CD5hi (black bars, n   5) CD45RBhi CD25  CD4 T cells.T
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them remained healthy. CD5 levels on sorted populations
did not change after transfer in vivo (Fig. 6 e). This suggests
that the predominance of CD5hi and CD5lo T cells in
healthy and sick animals respectively (Fig. 6 b) is the result
of selection and expansion rather than of conversion. These
results further emphasize that there are cells, distinct from
CD25  cells, in the normal T cell repertoire that can regu-
late the development of immune pathology. This happens
irrespective of antigen specificity by virtue of their high re-
sponsiveness to homeostatic signals in lymphopenic hosts.
Discussion
Regulation of peripheral T cell responses is an essential
feature in the immune system, preventing not only the de-
velopment of autoimmune disease, but also excessive re-
sponses to ‘foreign’ antigens that could lead to immune pa-
thology. Maintenance of tolerance to self in the periphery
as well as prevention of exaggerated outgrowth of activated
T cells after their stimulation by foreign antigen are funda-
mentally important functions of the immune system. Ro-
bustness in the mechanisms to achieve these goals is there-
fore expected and indeed a vast variety of peripheral
mechanisms have been described to exist for this purpose.
These include peripheral deletion (33, 34), differential ac-
tion of cytokines, including TGF-  (35) or IL-10- produc-
tion (36), self-antigen presentation by immature rather than
mature dendritic cells (37) or induction of anergy after sub-
optimal activation (38, 39), restriction of clonal expansion
by CTLA-4 (40), and Fas/Fas ligand interactions (41).
We have focused on the regulation of lymphopenia asso-
ciated immune pathology induced by an excessive T cell re-
sponse, presumably directed against commensal microor-
ganisms of the gut. The mouse model used in our
experiments is one of the most commonly used in vivo
models for the study of regulatory T cells. However, the
principles of regulation put forward in our study may also
apply for autoimmune diseases, such as diabetes in the NOD
mouse or BB rat model both of which exhibit a degree of
lymphopenia (42, 43). We have shown here, using the ex-
treme example of a monoclonal T cell receptor transgenic T
cell populations, that T cells lacking characteristic markers
ascribed to the regulatory lineage can function as regulatory
T cells. It should be emphasized that neither regulation by
monoclonal AND T cells nor self-regulation by high num-
bers of CD45RBhiCD25  T cells correlated with expression
of CD25, although CD25  T cells emerge in polyclonal T
cells even if they are transferred as CD45RBhiCD25  cells,
as also noted by Annacker et al. (44). In fact, AND T cells
from H-2b donors show a marked increase in CD25  cells
after transfer into lymphopenic hosts, yet these T cells failed
to act as regulatory T cells (45). Other studies have shown
that CD25  cells can have regulatory capacity and it was
suggested that both CD4 CD25  and CD4 CD25  regu-
latory cells exist (46, 47).
While it is highly unlikely that AND only regulate be-
cause they differentiate into one of the currently described
types of regulatory T cells in vivo, their capacity for regula-
tion correlated with rapid expansion potential in response
to endogenous MHC–peptide ligands in lymphopenic
hosts. Representative data on polyclonal CD4 T cell ex-
pansion suggest that AND reflect the behavior of a minor
(1%) subset of polyclonal T cells that divide more than 8
times within 7 d after transfer into lymphopenic hosts (48).
Previous studies using monoclonal transgenic T cells as a
source of regulatory T cells did not observe inhibition of
either EAE (49) or gastritis (50). It is not clear, however, in
these different experimental models if T cells from the
DO-11–10 strain used could expand early and sufficiently
enough to out-compete either polyclonal or MBP-specific
T cells even when subjected to immunization with ovalbu-
min. The expansion potential of AND T cells is excep-
tional and not shared by any other TCR transgenic popula-
tion available so that one could rightfully be concerned
about their representative value. However, we obtained
similar results with a monoclonal transgenic CD8 popula-
tion which divide substantially, if less than AND T cells,
upon transfer into lymphopenic mice. OT-I T cells offered
at least partial protection, supporting our claim that
homeostatic expansion and the resulting competition for
shared resources impacts on regulation of immune re-
sponses irrespective of specificity and phenotype of the
protective T cell population. Their reduced efficiency
compared with AND T cells could be due to less exagger-
ated proliferation or might also reflect differential homeo-
static requirements. Although naive CD4 and CD8 T cells
share the same peripheral niche (3), resources controlling
the number of activated/memory CD4 and CD8 T cells,
while partially overlapping (51), are not identical (52, 53)
so that one might expect only partial competition between
activated CD4 and CD8 T cells.
While our data do not rule out that regulatory cells func-
tion via release of inhibitory mediators such as IL-10 and/
or TGF- , they nevertheless suggest that a certain degree
of expansion is an essential prerequisite for manifestation of
regulatory function in vivo under conditions of lymphope-
nia. It is important to stress that regulatory function in vivo
need not correlate with suppressive activity in vitro, as we
show in these experiments. As far as the contribution of
homeostatic expansion to regulation is concerned, this is
understandable, as proliferation in lymphopenic hosts takes
place only in the microenvironment of lymphoid organs
(54) that would not be mimicked by any in vitro suspen-
sion culture.
Lymphocyte diversity can prevent the outgrowth of po-
tentially harmful cells by lymphocyte competition. In con-
trast, lymphopenia is invariably associated with homeostatic
expansion of the remaining T cells, resulting in an oligo-
clonal repertoire of a few clones that may become irrevers-
ibly dominant and cause pathology (55). Although the rules
that regulate T cell homeostasis are not entirely under-
stood, naive T cells depend on self-peptide:MHC and IL-7
signals for expansion, whereas for T cells with an activated
phenotype such as CD25  T cells IL-7 signals are not es-
sential for further expansion (56). Naive T cells exhibit
variable degrees of homeostatic expansion, reflecting theirT
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avidity for self peptide:MHC complexes and in some cases
homeostatic expansion can lead to activation, such that all
cells acquire characteristics typical for memory T cells. This
is exemplified by AND T cells which can be selected on
both H-2Ek for which they have very high affinity and
H-2Ab for which they have lower affinity (32), reflected in
dramatic proliferation and activation of AND T cells from
H-2Ek mice transferred into an H-2Ek environment and
more limited proliferation in an H-2b background (28, 54).
Similarly OT-I T cells were shown to divide in response to
self peptide:MHC ligands resulting in acquisition of an ac-
tivated phenotype (31).
T cell avidity for self peptide:MHC complexes not only
influences their potential for homeostatic expansion, but
also tunes their activation threshold in response to cognate
antigen. Up-regulation of CD5, a negative regulator of
TCR signaling, in the thymus ensures that thymocytes
with high avidity for self peptide:MHC are not overtly
self-reactive in the periphery because they display lower
responsiveness to cognate antigen (23). On the other hand
CD5hi T cells possess higher homeostatic expansion poten-
tial in response to self peptide:MHC signals than their
CD5lo counterparts (26). AND T cells on an H-2Ek back-
ground fulfill these criteria, being CD5hi, relatively insensi-
tive to CD3 stimulation, with a very high homeostatic po-
tential and the capacity to regulate expansion of other T
cells. We have shown here that polyclonal CD4 T
cells, depleted of putative regulatory T cells (CD45RBlo
CD25 ), exhibit self-regulatory activity, provided they
are injected in higher numbers. While the higher ho-
meostatic expansion potential of CD5hi T cells is not ev-
ident in completely lymphopenic mice, presumably due
to the excess of resources in that situation, they expand
more than CD5lo T cells in partially lymphopenic hosts
(26). This would explain why CD5hi T cells in the
CD45RBhi inoculum can prevent immune pathology in
recipients of higher (12   106) T cell numbers, whereas
they can only delay it in recipients of low T cell num-
bers (see Figs. 4 and 5). Therefore, T cell regulation by
transgenic T cells or self-regulation by high numbers of
CD45RBhiCD25  CD4 T cells might simply be the re-
sult of competition for limited homeostatic signals such
as IL-7 and MHC.
However, there are more levels of competition involved
in immune regulation. CD25  T cells are likely to com-
pete with any other T cell for access to antigen-carrying
APCs and growth factors such as IL-2. IL-2 signaling may
be involved in the regulatory function (46, 57–59) and
might underlie the differential capacities of AND versus
CD25  cells for in vitro regulation. Moreover, activated T
cells may directly or indirectly inhibit the expansion of rival
T cells by secretion of inhibitory cytokines, such as IL-10
and TGF- , both of which have been implicated in T cell
regulation (35, 36). Expression of CTLA-4, another
‘marker’ for regulatory T cells, represents yet another
mechanism by which activated T cells control their own
expansion, and presumably the expansion of other T cells
via induction of TGF-  (60).
The origin of CD45RBloCD25  found in the normal T
cell repertoire is currently unknown. Their functional
properties however, suggest that they may represent T
cells, which have acquired an activated phenotype by high
avidity interactions either in the thymus (57, 61) or the pe-
riphery. Interestingly, CD25  regulatory T cells have also
been reported to express high levels of CD5 (11), thus rep-
resenting T cells with high avidity for self-peptide:MHC;
their poor responsiveness to TCR stimulation in vitro and
in vivo is well documented (20, 62, 63). The CD25  T cell
population might also include effector cells transiently re-
sponding to their cognate antigen at that time. Therefore
there may exist, in addition to the independently regulated
pools of naive and memory T cells (3), a regulated pool of
effector T cells, which employs exploitation and interfer-
ence competition strategies to inhibit the expansion of rival
T cells as a bystander effect of their own expansion. The
existence of such a pool could also explain enhanced re-
sponses to nonimmunogenic tumors observed upon deple-
tion of CD4 CD25  cells (64, 65), suggesting that deple-
tion of the effector pool can make otherwise limited
resources available to the next wave of responding T cells.
In conclusion, our results show that T cell regulation, at
least in partially or fully lymphopenic states, can be effected
by members of the normal T cell repertoire. These need
not be dedicated suppressor T cells, but instead regulate T
cell responses as a side effect of their own response to ho-
meostatic and antigenic stimulation. Such context depen-
dent regulation has been proposed earlier on theoretical
grounds (66). Lymphopenia per se constitutes a high-risk
scenario for the development of pathological or autoim-
mune responses, yet so far little attention has been given to
the contribution of lymphocyte homeostasis and competi-
tion in prevention of immune dysregulation. Thus, further
definition of the mechanisms responsible for immune regu-
lation will inevitably depend on our understanding of the
consequences of perturbations in the control mechanisms
that maintain a balanced peripheral immune system.
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